Kliniska studier för Kramper i New Jersey
8 studier för Kramper söker deltagare vid platser i New Jersey.
Städer i New Jersey
Officiell studietext (engelska)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Tekton Research, Marlboro
RekryterarFas 3
Ålder 2 till 55 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison
- Saint Peter's University Hospital, New Brunswick
RekryterarFas 1
Ålder 12 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northeast Regional Epilepsy Group - Hackensack, Hackensack
- Hackensack Meridian Health Jersey Shore University Medical Center, Neptune City
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
- Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Neurology Center for Epilepsy and Seizures, Marlboro
RekryterarFas 3
Ålder 2 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT04462770A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 14 maj 2026 · NCT05716100Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Northeast Regional Epilepsy Group, Hackensack
RekryterarFas 3
Ålder 4 till 55 · Alla kön · Uppdaterad 24 juli 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Hackensack
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 3 apr. 2025 · NCT06908356Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.